LENZ Therapeutics (LENZ) Change in Inventory (2025 - 2026)
LENZ Therapeutics (LENZ) posted quarterly Change in Inventory of $889000.0 for Q1 2026, down 73.27% quarter-over-quarter from $3.3 million in Q4 2025.
LENZ Therapeutics (LENZ) Change in Inventory (2025 - 2026) Analysis & Trends
LENZ Therapeutics (LENZ) has reported Change in Inventory for 2 consecutive years, with $889000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Inventory changed N/A year-over-year to $889000.0; the TTM figure through Mar 2026 stood at $4.2 million (changed N/A YoY), while the FY2025 annual figure was $4.3 million, changed N/A from the prior year.
- Change in Inventory slipped to $889000.0 in Q1 2026 per LENZ's latest filing, from $3.3 million in the prior quarter.
- Across five years, Change in Inventory topped out at $3.3 million in Q4 2025 and bottomed at $889000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.75 Bn | 130.90 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.96 Bn | 77.96 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.33 Bn | 51.19 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.56 Bn | 28.25 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.32 Bn | 26.49 Bn | - | - |
| 10 | LENZ Therapeutics | 147.93 Mn | 147.93 Mn | 5.21 Mn | -19,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -19,000.00 |
| Jun 30, 2026 | -19,000.00 |
| Mar 31, 2026 | 889,000.00 |
| Mar 31, 2026 | 889,000.00 |
| Dec 31, 2025 | 3.33 Mn |
| Dec 31, 2025 | 3.33 Mn |